Sperling Prostate Center

Month: June 2023

Aspirin Reduces Risk of Mortality for Men with High-Risk Prostate Cancer

aspirin and prostate cancer mortality risk - Sperling Prostate Center
A few years ago I posted a blog on two published studies connecting the humble anti-inflammatory drug aspirin with less likelihood of prostate cancer recurrence among high-risk patients. The evidence of reduced PCa-specific mortality among high-risk patients who took daily aspirin was clear both. However, the exact mechanism by which aspirin may prevent the formation, progression, and metastasis of certain types of cancer cells was not fully understood.... keep reading
WordPress Image Lightbox